Nephrology
Latest News
Promising new antibiotic emerges for treating UTIs
It would be the first new treatment in 20 years for UTIs, which affect more than half of women at least sometime in their lives.
Conference Coverage
Study sheds new light on RAS inhibitors’ role for advanced CKD
“The results of this trial will inform future clinical practice worldwide and guideline recommendations.”
Conference Coverage
Moving the needle: SGLT2 inhibitor role for isolated kidney disease
When the EMPA-Kidney study began – before results from DAPA-CKD were known – “we never imagined such a large effect” on important endpoints in...
From the Journals
Kidney function may help docs pick antiplatelet mix after stroke
Ticagrelor–aspirin compared with clopidogrel-aspirin reduced risk for recurrent stroke with no substantial increase in severe or moderate bleeding...
Conference Coverage
Terlipressin decreases need for renal replacement therapy in liver transplant recipients
The drug restores renal blood flow and reverses hepatorenal syndrome type 1 in some patients.
From the Journals
Goodbye ‘diabetes insipidus’, hello ‘AVP-D’ and ‘AVP-R’
Confusion with the term ‘diabetes mellitus’ ... has spurred proposed name change by an international panel representing major endocrinology...
From the Journals
Islet transplants in type 1 diabetes durable up to 8 years
Long-term insulin independence and safety is seen with islet-cell transplant in patients with severe hypoglycemia at baseline.
From the Journals
‘Too good to be true’? Ultrasound safely treats kidney stones
The results of limited patient discomfort and stone motion in 66% of treated patients seem “almost too good to be true.”
From the Journals
Finerenone benefits T2D across spectrum of renal function
Finerenone treatment of people with type 2 diabetes and albuminuria improved outcomes, compared with placebo regardless of renal functional status...
Conference Coverage
Ultrasonic renal denervation passes 2-month test in uncontrolled HTN: RADIANCE II
No ill effects were seen in the sham-controlled trial of patients with uncontrolled mild to moderate hypertension. The approach led to significant...
Conference Coverage
No invasive strategy benefit at 5 years in ISCHEMIA-CKD extension study
The trial speaks to the lofty high-risk status of patients with CAD. ‘You’re seeing in a group of patients, with largely preserved EF but advanced...